Regulatory NewsBREAK July 2, 2024 Sept. 22, 2022: CMS Announced a 5-Year Increase in Medicare Part B Payment for Certain Biosimilar Biological Products, Effective Oct. 1, 2022
Regulatory NewsBREAK July 2, 2024 Sept. 28, 2022: CMS Releases Part D Guidance on Inflation Reduction Act Implementation
Regulatory NewsBREAK July 2, 2024 Nov. 2, 2022: CMS Issues Final Rule on Part B Immunosuppressive Drug Benefit